financetom
Business
financetom
/
Business
/
First Quantum CEO does not see Cobre Panama mine re-opening this year
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
First Quantum CEO does not see Cobre Panama mine re-opening this year
Jul 24, 2024 8:27 AM

July 24 (Reuters) - First Quantum CEO Tristan

Pascall said on Wednesday that he did not see Panama's Cobre

Panama copper mine re-opening this year.

The Cobre Panama mine is not in production since November

last year when the Panama government ordered the mine shutdown

due to public protests over environmental issues.

However Panama's newly elected President Jose Raul Mulino,

who took charge this month, indicated a possibility of re

opening the mine for its safe closure.

"We are open and committed to a dialogue with the new

administration in putting together a framework around which we

can have those conversations," Pascall said. "The timing of

which, we don't see happening this year as there (are) number of

complexities around it," he added.

The Cobre Panama mine contributed to 40% of First Quantum's

revenue and since the closure it has forced the company to carry

a series of capital restructuring measures to cut its ballooning

debt, including a pre-pay copper arrangement with its largest

shareholder Jiangxi Copper Co

On Tuesday, the company announced a shareholders rights

agreement Jiangxi Copper Co where the Chinese state

miner will not accumulate shares in the company or sell them in

block while the three-year shareholders rights agreement is in

effect.

Shares of First Quantum were trading up by 4% at the Toronto

Stock Exchange at 10:38 a.m. ET (1438 GMT), on Wednesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Muscle Disease Drug Developer Dyne Therapeutics Stock Plunges After Updated Data From Duchenne Muscular Dystrophy
Muscle Disease Drug Developer Dyne Therapeutics Stock Plunges After Updated Data From Duchenne Muscular Dystrophy
Sep 3, 2024
On Tuesday, Dyne Therapeutics Inc. ( DYN ) announced new clinical data from its ongoing Phase 1/2 DELIVER trial of DYNE-251 in patients with Duchenne muscular dystrophy (DMD) amenable to exon 51 skipping. This assessment of the DELIVER trial evaluating DYNE-251 includes 6-month biomarker and functional data from 8 male patients enrolled in the 20 mg/kg (approximate PMO dose) cohort...
BioVie Secures FDA Authorization for Phase 2 Study on Long COVID Treatment
BioVie Secures FDA Authorization for Phase 2 Study on Long COVID Treatment
Sep 3, 2024
12:40 PM EDT, 09/03/2024 (MT Newswires) -- BioVie ( BIVI ) said Tuesday the US Food and Drug Administration has authorized its investigational new drug application to evaluate bezisterim for treating neurological symptoms associated with long COVID. The approval allows BioVie ( BIVI ) to proceed with a phase 2 trial and positions the company to receive an additional $12.6...
Why Micron (MU) Stock Is Falling
Why Micron (MU) Stock Is Falling
Sep 3, 2024
Shares of Micron Technology Inc ( MU ) are trading lower by 5.78% to $90.69 during Tuesday’s session. The decline follows a post-earnings sell-off from industry leader Nvidia Corp, compounded by escalating geopolitical tensions, including the threat of Chinese retaliation against Japan’s export restrictions. Nvidia, a bellwether in the semiconductor industry, saw its shares sell-off following the company’s recent earnings...
Rite Aid to operate as private company as it emerges from Chapter 11 bankruptcy
Rite Aid to operate as private company as it emerges from Chapter 11 bankruptcy
Sep 3, 2024
(Reuters) -Rite Aid will operate as a private company as it has successfully completed its financial restructuring and emerged from Chapter 11 bankruptcy, the U.S. drugstore chain said on Tuesday. The pharmacy has used its bankruptcy to close hundreds of stores, sell its pharmacy benefit company Elixir, and negotiate settlements with its lenders, drug distribution partner McKesson and other creditors....
Copyright 2023-2026 - www.financetom.com All Rights Reserved